Scientific Digital Imaging Plc Trading update (5135H)
May 20 2014 - 2:00AM
UK Regulatory
TIDMSDI
RNS Number : 5135H
Scientific Digital Imaging Plc
20 May 2014
SCIENTIFIC DIGITAL IMAGING PLC
("SDI" or the "Company")
(AIM:SDI)
TRADING UPDATE
Scientific Digital Imaging plc, the AIM quoted group focused on
the application of digital imaging technology to the needs of the
scientific community, provides an update on trading for the year
ended 30 April 2014.
The Board expects to report a profit before and after tax for
the full year despite a small loss previously reported at the half
year. The recent acquisition of Opus Instruments completed near the
end of SDI's financial period and accordingly Opus's trading will
first have a full year effect in 2014/5. Revenues during the year
to 30 April 2014 were down slightly on the previous year, mainly
due to pressure experienced in sales of Syngene instrumentation.
Syngene, which produces equipment for life scientists to image and
analyse electrophoresis gels used for DNA and protein analysis, has
experienced pricing competition in the market place but this is
being combated by SDI with the introduction of a new lower cost
unit in the new financial year to 30 April 2015. Whilst below
previous management expectations, the Company has achieved a second
half profit and full year profit through the implementation of
on-going cost efficiencies which are also expected to benefit
trading in the new financial year.
Synoptics Health, which focuses on imaging technologies within
the clinical environment, has made further sales of its ProReveal
medical washroom product, with 26 demonstration units sold around
the world so far. The Company expect to make further progress in
the financial year to 30 April 2015 with a view to penetrating this
large addressable market.
Ken Ford, Chairman of SDI commented: "The Company's recent
successful acquisition of Opus Instruments demonstrates SDI's
commitment to its long-term buy and build strategy. The second half
profit and full year profit which we expect to report, together
with the ongoing investment in the continued evolution of the
Company's product range, gives the Board reason to remain
cautiously optimistic for trading in this new financial year."
The preliminary results for the year to 30 April 2014 will be
released in July 2014.
- Ends -
For further information please contact:
Scientific Digital Imaging plc
Ken Ford - Chairman
Mike Creedon - Chief Executive Officer
+44 1223 727144
finnCap
Ed Frisby/Ben Thompson - Corporate Finance
Mia Gardner - Corporate Broking
+44 20 7220 0500
JW Communications
Julia Wilson - Investor & Public Relations
+44 7818 430877
Note to Editors
About Scientific Digital Imaging plc
Scientific Digital Imaging plc (SDI) is focused on the
application of digital imaging technology to the needs of the
scientific and technology community. Its principal subsidiary is
Synoptics Limited, which designs and manufactures special-purpose
instruments for use mainly in the life sciences, supplying
customers in the academic, research and health sectors. Within
Synoptics, the recently formed Synoptics Health division has
launched the Synoptics Health ProReveal system. This patented
system offers a highly sensitive fluorescence-based test to detect
dirty surgical instruments in hospitals and aims to reduce
incidences of cross contamination of patients. In addition, under
the Atik brand, SDI designs and manufactures high-sensitivity
cameras for both astronomical and life science applications.
www.scientificdigitalimaging.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTSFMFMUFLSESI
Sdi (LSE:SDI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sdi (LSE:SDI)
Historical Stock Chart
From Sep 2023 to Sep 2024